Skip to main content
Skip to main content
VEXTF logo

Vext Science, Inc. (VEXTF) Stock Analysis

$0.2197 +$0.0197 (+9.85%) |CouncilSplit View · 37 · D
Vext Science, Inc. (VEXTF) bottom line: Split View — our Council read (37/100) and AI Score (43/100) broadly agree. Strongest signal: Ray Dalio bullish · Biggest watch-out: Seth Klarman bearish.
MCap: $54.4M| Vol: 2.2K| 52-wk range: $0.10 – $0.3176
Data from FMP · Methodology

For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Vext Science, Inc. (VEXTF) trades at $0.2197 with AI Score 43/100 (Grade C). Vext Science, Inc. operates as a vertically integrated cannabis enterprise in the U. S. Market cap: $54.4M, Sector: Healthcare.

Price as of Aug 21, 2026 · Last analyzed: Jun 14, 2026
Vext Science, Inc. operates as a vertically integrated cannabis enterprise in the U.S., focusing on cultivation, extraction, manufacturing, and distribution of THC and CBD products. The company manages retail dispensaries and wholesale channels, marketing products under brands like Vapen and Pure Touch Botanicals, primarily within the Arizona market.

Analyst Coverage for VEXTF: VEXTF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates VEXTF against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.

Watch the VEXTF film Every key number, told as a short cinematic story — just press play. ~2 min
Council Score · Weighted Average of 3 Disciplines
Split View 37/100 · D

VEXTF: 1/3 scored disciplines lean bearish. Dominant signal: Ray Dalio bullish.

How is this calculated? →
Legends Council · 5 Legends + Moon AI
Ray Dalio
Bullish
Izzy Englander
Bearish
Seth Klarman
Bearish
Moon AI
Bearish
Munger's Mindset · Balance Sheet & Valuation
Financial Health
Negative
Margin of Safety
Undervalued
Council Score · Weighted Average of 3 Disciplines · See tabs for details →

Why this analysis is different

  • A 9-signal quantitative MoonshotScore built from filings, insider activity, and market data — computed from the numbers, not from opinion.
  • An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
  • Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.

Vext Science, Inc. (VEXTF) Healthcare & Pipeline Overview

CEOEric J. Offenberger
Employees173
HeadquartersPhoenix, US
IPO Year2019

Vext Science, Inc. operates as a vertically integrated cannabis enterprise in the U.S., focusing on cultivation, extraction, manufacturing, and distribution of THC and CBD products under brands like Vapen and Pure Touch Botanicals. Headquartered in Phoenix, Arizona, the company manages retail dispensaries and wholesale channels, positioning itself within the evolving specialty drug manufacturing segment of the healthcare sector.

Data Provenance | Financial Data Quantitative Analysis Analysis: Jun 14, 2026

What Is the Investment Thesis for VEXTF?

As of Jun 14, 2026 — figures reflect the data available on that date.

Vext Science, Inc. presents an investment profile centered on its vertically integrated operations within the U.S. cannabis sector, primarily focused on Arizona. With a market capitalization of $54.4M, the company leverages its control over cultivation, extraction, manufacturing, and distribution to manage product quality and supply chain efficiency. Key growth catalysts include the ongoing expansion of its Vapen and Pure Touch Botanicals brands, especially through its Vapen Kitchens line of diverse edibles, which can capture evolving consumer demand. Further opportunities lie in potential market share gains within its core Arizona market and the broader U.S. cannabis industry as regulatory landscapes evolve. However, the company faces significant challenges, evidenced by a profit margin of -30.2%, indicating a current lack of profitability. Ongoing regulatory risks associated with the fragmented and evolving legal status of cannabis at state and federal levels pose a material threat. Investors should evaluate the company's ability to achieve profitability and navigate regulatory complexities while capitalizing on its established operational infrastructure and brand presence.

Based on FMP financials and quantitative analysis

VEXTF Key Highlights

Market capitalization stands at $0.05 billion, reflecting its valuation within the specialty drug manufacturing sector.

  • Reported a profit margin of -30.2%, indicating current unprofitability in its operations.
  • Achieved a gross margin of 23.8%, demonstrating the profitability of its core product sales before operating expenses.
  • Maintains a Beta of 0.76, suggesting lower volatility compared to the broader market.
  • Employs a workforce of 173 individuals, supporting its vertically integrated cannabis operations.

Who Are VEXTF's Competitors?

VEXTF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap AI Score
GDNSF Goodness Growth Holdings, Inc. $0.45 +0.00% $61.1M 64
MNNGF Baijin Life Science Holdings Limited $0.08 +0.00% $74.6M 63
SHIEF Shield Therapeutics plc $0.07 +0.00% $75.3M 62
ETST Earth Science Tech, Inc. $0.12 +14.45% $35.3M 61
GBLP Global Pharmatech, Inc. $0.08 +0.00% $33.3M 62
CNVCF BioHarvest Sciences Inc. $6.30 +0.00% $109M 66
GENH Generation Hemp, Inc. $0.22 +0.00% $25.3M 63
CPHRF Cipher Pharmaceuticals Inc. $10.28 +0.39% $261M 63

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are VEXTF's Key Strengths?

Vertically integrated operations provide control over the supply chain and product quality.

  • Established and recognized brands such as Vapen and Pure Touch Botanicals.
  • Diverse product portfolio including vape cartridges, concentrates, and a wide range of edibles.
  • Presence in the U.S. cannabis market, particularly with a focus on Arizona.

What Are VEXTF's Weaknesses?

Negative profit margin of -30.2% indicates current unprofitability.

  • Limited geographic reach, primarily concentrated in the Arizona market.
  • Reliance on the evolving and often restrictive regulatory landscape of the U.S. cannabis industry.
  • Operating on the OTC market, which can present challenges related to liquidity and investor perception.

What Could Drive VEXTF Stock Higher?

Strategic expansion and optimization of its vertically integrated cannabis operations within the Arizona market.

  • Continuous development and diversification of its product portfolio, particularly the Vapen Kitchens line of edibles, to meet evolving consumer demand.
  • Potential for favorable legislative or regulatory changes at the state level that could expand market access or reduce operational burdens for cannabis businesses.
  • Implementation of new agricultural technologies aimed at improving cultivation efficiency and product consistency, potentially enhancing gross margins.

What Are the Key Risks for VEXTF?

Financial-distress signal — its Altman Z-Score of 0.54 sits in the distress zone (elevated bankruptcy risk).

  • Negative return on equity (-25.2%) — the business is not currently generating profit on shareholder capital.
  • Significant regulatory risks stemming from the complex and evolving legal status of cannabis at both state and federal levels in the U.S.
  • Persistent unprofitability, as indicated by a negative profit margin of -30.2%, posing challenges for sustainable growth and capital generation.
  • Intense competition from well-capitalized multi-state operators and other established players within the U.S. cannabis market.
  • Challenges associated with operating on the OTC Other market, including limited liquidity, transparency, and potential for price volatility.
  • Economic downturns or shifts in consumer discretionary spending habits that could negatively impact demand for cannabis products.

What Are the Growth Opportunities for VEXTF?

  • **Expansion within the Arizona Market:** Vext Science, Inc. can capitalize on its established presence and vertically integrated model within Arizona to deepen its market penetration. By optimizing its retail dispensary network and enhancing wholesale distribution channels, the company can capture a larger share of the state's growing cannabis consumer base. This strategy leverages existing infrastructure and brand recognition (Vapen, Pure Touch Botanicals) to drive revenue growth, potentially through targeted marketing campaigns and loyalty programs. The Arizona market continues to mature, offering sustained opportunities for companies with efficient supply chains and diverse product portfolios.
  • **Product Line Diversification and Innovation:** The cannabis market is characterized by evolving consumer preferences. Vext Science can drive growth by continuously innovating and expanding its product lines, particularly within its Vapen Kitchens edibles. Introducing new flavors, formulations, and product types (e.g., beverages, tinctures, specific cannabinoid ratios) can attract new customer segments and increase per-customer spending. This approach allows the company to stay competitive and relevant, catering to niche demands while reinforcing its reputation for quality and variety across its THC and CBD offerings.
  • **Leveraging Agricultural Technology for Efficiency:** By investing further in advanced agricultural technology and cultivation techniques, Vext Science can enhance operational efficiency, reduce production costs, and improve yield and consistency of its cannabis crops. This focus on ag-tech can lead to higher gross margins and improved profitability, which is crucial given the current negative profit margin. Implementing data-driven cultivation practices and sustainable methods can also serve as a competitive differentiator, appealing to environmentally conscious consumers and investors.
  • **Strategic Brand Building and Market Share Enhancement:** Strengthening the Vapen and Pure Touch Botanicals brands through consistent quality, effective marketing, and consumer engagement initiatives represents a significant growth opportunity. A strong brand identity can foster customer loyalty and command premium pricing, even in a competitive market. Focused efforts on digital presence, community outreach, and product education can elevate brand perception and drive increased sales volume, securing a more defensible market position within its operating regions.
  • **Potential for Interstate Commerce and New State Markets:** While currently constrained by federal prohibition, any future legislative changes allowing for interstate cannabis commerce or broader federal legalization would unlock substantial growth opportunities for Vext Science. This could enable the company to expand its wholesale and retail operations into new, high-growth state markets without establishing entirely new cultivation and manufacturing facilities in each state. Monitoring and preparing for such regulatory shifts could position Vext Science to rapidly scale its operations and brand presence across a wider geographic footprint.

What Are VEXTF's Competitive Advantages?

  • **Vertically Integrated Operations:** Controls the entire supply chain from cultivation to retail, ensuring product quality, consistency, and cost efficiency.
  • **Established Brand Portfolio:** Owns recognized brands like Vapen, Pure Touch Botanicals, and Vapen Kitchens, fostering consumer trust and loyalty.
  • **Retail Dispensary Network:** Direct access to consumers through its own dispensaries provides valuable market insights and control over the customer experience.
  • **Product Diversification:** Offers a broad range of THC and CBD products, including vapes, concentrates, and a comprehensive edibles line, catering to varied consumer demands.
  • **Regional Market Focus:** Deep understanding and operational efficiency within its primary market, Arizona, allowing for tailored strategies and strong local presence.

What Does VEXTF Do?

Established in 2015, Vext Science, Inc., initially known as Vapen MJ Ventures Corporation before its rebranding in November 2019, has evolved into a comprehensive enterprise within the dynamic United States cannabis sector. Headquartered in Phoenix, Arizona, the company's operational scope spans agricultural technology, various services, and property management, underscoring its commitment to a vertically integrated business model. This integration allows Vext Science to exert greater control over its entire supply chain, from cultivation to the final distribution of its diverse product offerings. The company is actively involved in the cultivation of cannabis, followed by the extraction of cannabinoids, and the manufacturing of a wide array of THC and CBD products. These include popular forms such as vape cartridges, concentrates, and edibles, catering to a broad spectrum of consumer preferences. Beyond its production capabilities, Vext Science, Inc. strategically manages its own network of retail dispensaries, providing direct-to-consumer access to its products. Concurrently, it maintains a robust wholesale distribution network for both cannabis-derived THC products and hemp-derived CBD products. These offerings are prominently marketed under its proprietary brands, Vapen and Pure Touch Botanicals, which have established a presence in the market. A significant component of its product portfolio is the Vapen Kitchens line, which specializes in infused edibles. This line features a diverse selection, including Vapen clear products, THC chocolate bars, various syrups, snacks, and an assortment of candies, notably gummies. By encompassing cultivation, manufacturing, distribution, and retail, Vext Science, Inc. aims to solidify its market position within the U.S. cannabis industry, particularly with a focus on the Arizona market, leveraging its integrated operations to maintain product quality and market reach.

What Products and Services Does VEXTF Offer?

  • Cultivates cannabis utilizing agricultural technology.
  • Extracts cannabinoids (THC and CBD) from cultivated cannabis.
  • Manufactures a diverse range of cannabis products, including vape cartridges, concentrates, and edibles.
  • Distributes cannabis-derived THC and hemp-derived CBD products through wholesale channels.
  • Operates retail dispensaries to sell its branded cannabis products directly to consumers.
  • Develops and markets proprietary brands such as Vapen, Pure Touch Botanicals, and Vapen Kitchens.
  • Manages various services and property related to its cannabis operations.
  • Produces a specific line of infused edibles under Vapen Kitchens, including chocolates, syrups, snacks, and gummies.

How Does VEXTF Make Money?

  • Generates revenue through the direct sale of THC and CBD products via its owned and operated retail dispensaries.
  • Earns income from the wholesale distribution of cannabis-derived THC products to other licensed retailers.
  • Derives revenue from the wholesale distribution of hemp-derived CBD products to various market channels.
  • Monetizes its Vapen Kitchens line through the manufacturing and sale of infused edibles.

What Industry Does VEXTF Operate In?

Vext Science, Inc. operates within the "Drug Manufacturers - Specialty & Generic" industry, specifically focusing on the U.S. cannabis sector, which is a rapidly evolving segment of the broader healthcare landscape. This industry is characterized by significant regulatory fragmentation, with cannabis remaining federally illegal while numerous states have legalized it for medical or adult recreational use. Market trends indicate a strong demand for diverse cannabis products, including vapes, concentrates, and edibles, driving innovation in product development and delivery methods. Vext Science positions itself as a vertically integrated player, encompassing cultivation, manufacturing, and retail, which provides a competitive advantage by allowing greater control over product quality and supply chain logistics. While the company's primary focus is the Arizona market, it competes with both established multi-state operators and smaller, localized cannabis businesses. The competitive landscape is intense, with companies vying for market share through brand differentiation, product innovation, and retail presence. Vext Science's strategy relies on its Vapen and Pure Touch Botanicals brands to distinguish itself in this dynamic environment.

Who Are VEXTF's Key Customers?

  • Adult-use cannabis consumers in states where recreational cannabis is legal.
  • Medical cannabis patients seeking therapeutic products in regulated markets.
  • Licensed cannabis dispensaries and retailers purchasing products for wholesale distribution.
  • Consumers interested in hemp-derived CBD products for wellness purposes.
AI Confidence: 68% Updated: Jun 14, 2026
ROE -25%

Key Financial Metrics

Return on equity for Vext Science, Inc. stands at -25.2%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -13.4%, showing how much profit it generates from its asset base. Its free cash flow yield is 14.3%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.62 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is -31.7%, the inverse of the P/E and a quick read on earnings relative to price.

Vext Science, Inc. (VEXTF) Valuation Context

Valued at $54.4M, VEXTF is classified as a micro-cap stock. Relative to its peer group, VEXTF's quantitative score of 43/100 is below the peer average of 62/100.

Company Profile

Vext Science, Inc. operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. It is headquartered in Phoenix, CA. The company is led by CEO Eric J. Offenberger. VEXTF has traded publicly since 2019.

F-Score 4/9

Financial Health

Vext Science, Inc.'s Piotroski F-Score is 4/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 0.54 places it in the distress zone, a signal of elevated financial risk.

FY2026 est

Forward Outlook

Wall Street analysts project Vext Science, Inc. revenue of about $66.6M for fiscal 2026, with EPS near $-0.02.

VEXTF Financials

Fundamental Snapshot

Revenue Growth (FY)
+45.2%
Net Income Growth (FY)
+18.4%
EPS Growth (FY)
+20.5%
Free Cash Flow Growth (FY)
+354.5%
Return on Equity (TTM)
-25.2%
Current Ratio
0.6
EV/EBITDA (TTM)
8.5

Based on FMP financials and quantitative analysis · FY 2025

Bull Case vs Bear Case

Bull Case

  • AI analysis temporarily unavailable
  • Check back shortly for updated insights
  • Market sentiment data being refreshed
  • Community discussions being analyzed

Bear Case

  • AI analysis temporarily unavailable
  • Check back shortly for updated insights
  • Risk factors being evaluated
  • Market concerns being processed

AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026

VEXTF Latest News

No recent news available for VEXTF.

VEXTF Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for VEXTF.

Price Targets

Wall Street price target analysis for VEXTF.

VEXTF MoonshotScore

43/100

What does this score mean?

The MoonshotScore rates VEXTF 0-100 on quantitative fundamentals — growth, financial health, valuation, momentum, and risk.

Leadership: Eric J. Offenberger

CEO

Unknown. Information regarding Eric J. Offenberger's specific career history, educational background, and previous roles prior to his tenure at Vext Science, Inc. was not provided in the source data. His professional credentials beyond his current role as CEO are also not available from the provided information.

Track Record: Unknown. Details regarding key achievements, strategic decisions, or specific company milestones directly attributable to Eric J. Offenberger's leadership at Vext Science, Inc. were not provided in the source data. The available information does not specify the duration of his tenure or any particular successes during his time as CEO.

VEXTF OTC Market Information

Vext Science, Inc. trades on the OTC market under the "OTC Other" tier. This tier represents companies that do not meet the disclosure requirements for OTCQX or OTCQB, or choose not to be listed on those tiers. Unlike major exchanges such as the NYSE or NASDAQ, which have stringent listing standards for financial reporting, corporate governance, and minimum share prices, the OTC Other tier has minimal to no public disclosure requirements. This classification often indicates a higher risk profile for investors due to reduced transparency and oversight compared to companies on higher OTC tiers or national exchanges.

  • OTC Tier: OTC Other
Liquidity: Trading on the OTC Other tier typically implies significantly lower liquidity compared to major exchanges. Investors may experience wider bid-ask spreads, meaning a larger difference between the price buyers are willing to pay and sellers are willing to accept. This can lead to higher transaction costs and difficulty in executing large orders without impacting the stock price. The trading volume for VEXTF is likely lower, making it challenging for investors to enter or exit positions quickly without substantial price fluctuations.
OTC Risk Factors:
  • Lack of comprehensive and timely financial disclosure, making it difficult for investors to assess the company's true financial health.
  • Significantly lower trading volume and wider bid-ask spreads, leading to poor liquidity and potential difficulty in buying or selling shares.
  • Increased susceptibility to price manipulation and volatility due to limited regulatory oversight and transparency.
  • Limited analyst coverage and institutional investor interest, which can hinder fair valuation and market awareness.
  • Higher risk of delisting or cessation of trading if the company fails to meet even minimal operational or disclosure requirements.
Due Diligence Checklist:
  • Thoroughly review any available financial statements, even if unaudited or limited, to assess revenue, expenses, and cash flow.
  • Investigate the company's business model, products, and market position independently, as third-party analysis may be scarce.
  • Scrutinize management's background and track record, seeking information beyond what is publicly disclosed on OTC Markets.
  • Assess the company's regulatory compliance history, especially given its operation in the highly regulated cannabis sector.
  • Evaluate the company's capital structure, outstanding shares, and potential for dilution from future offerings.
  • Research any legal or administrative actions against the company or its management.
  • Understand the specific risks associated with the cannabis industry, including evolving regulations and competition.
Legitimacy Signals:
  • Operates an actual business involved in cultivation, manufacturing, and distribution of cannabis products.
  • Maintains a physical headquarters in Phoenix, US, indicating a tangible operational base.
  • Employs 173 individuals, suggesting a substantive workforce and ongoing operations.
  • Markets products under established brands such as Vapen and Pure Touch Botanicals, indicating brand development efforts.
  • Engages in retail dispensary management and wholesale distribution, demonstrating active market participation.

Vext Science, Inc. Healthcare Stock: Key Questions Answered

What does the AI Score mean for VEXTF?

VEXTF holds an AI Score of 43/100 (Grade: C). This is an educational research signal, not a buy or sell recommendation. Vext Science, Inc. operates as a vertically integrated cannabis enterprise in the U.S., focusing on cultivation, extraction, manufacturing, and distribution of THC and CBD products. The company …

What does Vext Science, Inc. do?

Vext Science, Inc. operates as a vertically integrated enterprise within the United States cannabis sector, headquartered in Phoenix, Arizona. The company's core activities encompass the cultivation, extraction, manufacturing, and distribution of both THC and CBD products.

What are Vext Science, Inc.'s key product lines and how do they contribute to its market strategy?

Vext Science, Inc. primarily offers THC and CBD products through its Vapen and Pure Touch Botanicals brands. The Vapen brand is central to its cannabis-derived THC offerings, encompassing vape cartridges, concentrates, and a comprehensive edibles line under Vapen Kitchens, which includes THC chocolate bars, syrups, snacks, and various candies like gummies. Pure Touch Botanicals focuses on hemp-derived CBD products.

What are the primary regulatory challenges Vext Science, Inc. faces as a cannabis operator in the U.S. healthcare sector?

As a cannabis operator in the U.S., Vext Science, Inc. navigates a complex and often contradictory regulatory landscape. The primary challenge stems from cannabis remaining federally illegal, which creates significant hurdles for interstate commerce, banking, and taxation, despite state-level legalization.

What are the implications of Vext Science, Inc. trading on the OTC market for investors?

Vext Science, Inc.'s listing on the OTC Other tier of the OTC market carries several implications for investors. This tier typically signifies minimal public disclosure requirements, which can lead to limited transparency regarding the company's financials and operations, making comprehensive due diligence challenging.

What are the key factors to evaluate for VEXTF?

Vext Science, Inc. (VEXTF) holds an AI score of 43/100 (low). presents an investment profile centered on its vertically integrated operations within the U.S. Not financial advice.

How frequently does VEXTF data refresh on this page?

VEXTF's price was last updated on Aug 21, 2026 and refreshes on page view during U.S. market hours — it is not a real-time exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.

What has driven VEXTF's recent stock price performance?

Vext Science, Inc. (VEXTF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Vertically integrated operations provide control over the supply chain and product quality. See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider VEXTF overvalued or undervalued right now?

Vext Science, Inc. (VEXTF) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated AI Score refreshed daily
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • No FMP PEER TICKERS were provided in the source data for competitors.
  • CEO background and track record details were not provided in the source data.
  • Disclosure status for OTC tier is explicitly stated as 'Unknown' in the source data.

Popular Stocks

More Stocks We Cover